Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic Leukemia
Nina S. Kadan‐Lottick(Georgetown University), Joseph P. Neglia(University of Minnesota), David Breiger(University of Washington), Megan Nicoletti(Yale Cancer Center), Veronika Northrup(Children's Oncology Group), James Dziura(Yale University), Pim Brouwers(National Institutes of Health), Linda C. Stork(Oregon Health & Science University), Bruce Bostrom(Minnesota West Community & Technical College), Lü Chen(Wuhan University), Thomas A. Kaleita(University of California, Los Angeles)
Cited by 68
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline
|Journal of Clinical Oncology|2004|709
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
|New England Journal of Medicine|2016|576